Turing’s Martin Shkreli regrets 5,000% price hike—says it wasn’t high enough | Ars Technica


In a Healthcare summit hosted by Forbes on Thursday, Martin Shkreli, the founder and CEO of Turing Pharmaceuticals, admitted he made a mistake by raising the price of a decades-old drug by more than 5,000 percent. But it’s not the mistake you might expect.

Source: Turing’s Martin Shkreli regrets 5,000% price hike—says it wasn’t high enough | Ars Technica

Leave a Reply

Your email address will not be published. Required fields are marked *

17 − six =